[1]
2024. Polymeric Nanoparticle-Mediated Delivery of Oncolytic Measles Virus for Targeted Therapy in Cervical Cancer. Pharmaceutical Communications. 3, 01 (Jun. 2024). DOI:https://doi.org/10.55627/pharma.003.001.0887.